Key result
Multidisciplinary CAD management optimizes outcomes in lung transplant candidates.
Why the study?
Lung transplant candidates must be critically assessed for operative risk and cardiovascular health, of which coronary artery disease is a major determinant.
Careful multidisciplinary assessment and management of coronary artery disease in lung transplant candidates can mitigate perioperative and long-term cardiovascular risks, allowing patients with CAD to safely undergo transplantation.
Supports multidisciplinary CAD evaluation in lung transplant candidates; leaves open the need for prospective trials to confirm benefits.
Lung transplantation can greatly improve quality of life and extend survival in those with end-stage lung disease. In order to derive the maximal benefit from such a procedure, patients must be carefully selected and be otherwise healthy enough to survive a high-risk surgery and sometimes prolonged immunosuppressive therapy following surgery. Patients therefore must be critically assessed prior to being listed for transplantation with close attention paid towards assessment of cardiovascular health and operative risk. One of the biggest dictators of this is coronary artery disease. In this review article, we discuss the assessment and management of coronary artery disease in the potential lung transplant candidate.
No takes yet. Share an insight, caveat, or question.
Serrao et al. (2023) conducted a review in Coronary Artery Disease in Lung Transplant Candidates. Coronary artery disease evaluation and management was evaluated. Multidisciplinary evaluation and management of coronary artery disease using contemporary strategies is crucial for optimizing outcomes in lung transplant candidates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: